IDDORVY
Live / Applied — Second extension granted (statement of use) (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 22 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98564352
- Mark type
- Stylized text
- Filed
- 22 May 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Cynthia Smuzynska
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical and biological preparations for use in immunotherapy, in particular, T-Cell immunotherapy; pharmaceutical preparations for the treatment of oncological and blood disorders
Owner
- Kite Pharma, Inc., Santa Monica, CA, US
- Kite Pharma, Inc., Santa Monica, CA, US
Prosecution history
- 07 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 2 GRANTED
- 07 Jan 2026 — SOU EXTENSION 2 FILED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2025 — SOU EXTENSION 1 GRANTED
- 16 Jul 2025 — SOU EXTENSION 1 FILED
- 16 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Dec 2024 — EXAMINER'S AMENDMENT ENTERED
- 09 Dec 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED